Bystolic

Links shared publicly online about this topic

iGuard.org - Bystolic Drug Interactions, Bystolic Side Effects and Bystolic Patient Reviews

iguard.org — “iGuard.org - Bystolic Drug Interactions, Bystolic Side Effects and Bystolic Patient ReviewsView full resource at iguard.org

  • View Related
  • Share

Most Recently Shared on December 24, 2009 at 10:17 pm By:

FDA recommends against nebivolol (Bystolic) approval for heart failure

theheart.org — “In documents released prior to next week's advisory panel meeting, the agency noted irregularities in how the supporting clinical trial was executed and said its findingsView full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on January 7, 2010 at 10:03 pm By:

theheartorg Shelley Wood Cardiology

FDA will argue against nebivolol approval for HF http://bit.ly/4VAVFF #heartwire

2 years ago...

PharmaLive: Forest Laboratories Enters Collaboration on Bystolic and Savella in Canada

pharmalive.com — “PharmaLive: Forest Laboratories Enters Collaboration on Bystolic and Savella in CanadaView full resource at pharmalive.com

  • View Related
  • Share

Most Recently Shared on November 12, 2010 at 7:39 pm By:

pharmalive PharmaLive Pharma and Health News

Forest Inks Marketing Deals With J&J Units - http://tinyurl.com/2f2hdvt

2 years ago...

Comments of using Bystolic (study 6211391) - eHealthMe.com

ehealthme.com — “severe itching. Is there an interaction between the two?View full resource at ehealthme.com

  • View Related
  • Share

Most Recently Shared on March 27, 2012 at 6:28 pm By:

eHealthMe eHealthMe.com Health Site

severe itching. Is there an interaction between the two? http://t.co/d6cXs7Vf

2 months ago...

Just Started Bystolic (Newest posts first) - The People's Medicine Community

prescriptiondrug-info.com — “I just started on bystolic and am unsure how often to take it After 14 hours my bp is very good and a bit low I don t know whether to take another with my bp at this rate 117 74 Would it drop too low Should I take it anyway to remain on a schedule So confused Sandy it really isn t as effective if us (Newest posts first)View full resource at prescriptiondrug-info.com

  • View Related
  • Share

Most Recently Shared on October 1, 2011 at 5:35 pm By:

druginfo Medicine Community Support

" Sandy, it really isn't as effective if used that way. I am not sure why your doctor told you that, but for http://t.co/CRrEcjcR

8 months ago...

Comments of using Bystolic (study 6123598) - eHealthMe.com

ehealthme.com — “Is there any reason I should not take Co-q10 with vit E and mixed tocopherols?View full resource at ehealthme.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 4:56 pm By:

eHealthMe eHealthMe.com Health Site

Is there any reason I should not take Co-q10 with vit E and mixed tocopherols? http://t.co/MTdZdwsq

2 months ago...

Watson Confirms BYSTOLIC Patent Challenge - Drugs.com MedNews

drugs.com — “- Paragraph IV Litigation Underway - Watson Pharmaceuticals, Inc. (NYSE WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an AbbreviateView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 11:03 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Watson Confirms BYSTOLIC Patent Challenge: - Paragraph IV Litigation Underway -   PARSIPPANY, N.J., March ... http://t.co/SxeRjCzc #drug

2 months ago...

Data from Phase IV study of Bystolic tablets in Hispanic patients with hypertension presented at ASH 2010

news-medical.net — “Forest Laboratories, Inc. today presented data from a Phase IV study evaluating the effects of Bystolic (nebivolol) tablets in Hispanic patients with hypertension at the 2010 annual scientific meeting of the American Society of Hypertension.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 4, 2010 at 6:01 am By:

Pregnancy_News News-Medical.Net Health News

Pregnancy News: Data from Phase IV study of Bystolic tablets in Hispanic patients with hypertension presented at A... http://bit.ly/cSShQV

2 years ago...

Forest Laboratories' Bystolic tablets for treatment of stable CHF failed to receive FDA approval

news-medical.net — “Forest Laboratories, Inc. announced today that the U.S. Food and Drug Administration did not approve the additional indication for Bystolic® (nebivolol) tablets as a treatment for stable chronic heart failure (CHF) as requested in the company's Supplemental New Drug Application (sNDA).View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on February 24, 2010 at 10:23 am By:

Pregnancy_News News-Medical.Net Health News

Pregnancy News: Forest Laboratories' Bystolic tablets for treatment of stable CHF failed to receive FDA approval: ... http://bit.ly/c1sikf

2 years ago...

Bystolic satisfaction and usage data | Monitoring more than 2,000 patients | Drug safety information | MediGuard

mediguard.org — “Bystolic satisfaction and usage data | Monitoring more than 2,000 patients | Drug safety information | MediGuardView full resource at mediguard.org

  • View Related
  • Share

Most Recently Shared on April 29, 2011 at 1:17 pm By:

Forest Laboratories Receives Decision From FDA For Supplemental New Drug Application For Bystolic(R)

medicalnewstoday.com — “Forest Laboratories, Inc. (NYSE: FRX) announced that the U.S. Food and Drug Administration (FDA) did not approve the additional indication for Bystolic(R) (nebivolol) tablets as a treatment for sView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 27, 2010 at 4:05 pm By:

mnt_heart MNT Heart News Health News

Forest Laboratories Receives Decision From FDA For Supplemental New Drug Application For Bystolic(R) http://mnt.to/3yfL #heart #heartdisease

2 years ago...

UPDATE 2-US FDA staff against wider approval of Forest drug | Reuters

reuters.com — “* FDA staff: Evidence does not back heart failure claim * Advisory panel to review wider use Monday * Company says drug helps elderly patients * Shares fall 0.7 pct (Adds FDA, company comments,View full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on January 7, 2010 at 6:41 pm By:

ReutersLisaRx Lisa Richwine Health Communicator

FDA reviewer urges against OK of Forest hypertension drug Bystolic in heart failure, advisory panel meets Mon http://link.reuters.com/vew32h

2 years ago...

Medical News: FDA Panel Rejects Bid to Broaden Beta Blocker Indication - in Cardiovascular, CHF from MedPage Today

medpagetoday.com — “WASHINGTON -- A cardiovascular advisory panel has unanimously agreed that the FDA should not expand the indications for the beta blocker nebivolol (Bystolic) to include treatment of heart failure in oView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on January 12, 2010 at 12:07 am By:

medical_tweets medical_tweets Health News

FDA Panel Rejects Bid to Broaden Beta Blocker Indication WASHINGTON (MedPage Today) -- A cardiovascular advisory pane.. http://bit.ly/8QVPRG

2 years ago...

FDA panel rejects new use for beta blocker - Heart health- msnbc.com

msnbc.msn.com — “Federal health advisers say unanimously that Forest Laboratories' hypertension drug should not be approved for a new use in patients at risk for heart failure.View full resource at msnbc.msn.com

  • View Related
  • Share

Most Recently Shared on January 11, 2010 at 10:13 pm By:

Beta-blocker benefit in SENIORS independent of LVEF

theheart.org — “Heart-failure patients at least 70 years old who took nebivolol in the randomized trial had similar reductions in all-cause mortality or CV hospitalization, whether their LVEF was below or above 35%.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on June 12, 2009 at 6:12 pm By:

theheartorg Shelley Wood Cardiology

heartwire: Beta-blocker benefit in SENIORS independent of LVEF http://bit.ly/vTlXw

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • MediGuard

    MediGuard.org

    Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.

    View Profile

  • theheartorg

    Shelley Wood

    Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4

    View Profile

  • pharmalive

    PharmaLive

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390